Single and Multiple Dose Escalation Study of VX-509 in Healthy Subjects
Clinical trial NCT00789126 · COMPLETED
Trial details
- NCT number
- NCT00789126
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.